Will I Pass Hereditary Spherocytosis to My Child?
At a Glance
In about 75% of cases, hereditary spherocytosis is autosomal dominant, meaning you have a 50% chance of passing it to each child. A genetic counselor can identify your exact gene mutation and help you understand your specific risks and family planning options.
If you have hereditary spherocytosis (HS), the chances of passing it on to your child depend on the specific genetic form of the condition you have. For most people (about 75% of cases), HS is inherited in an autosomal dominant pattern, meaning there is a 50% chance of passing the condition to each child [1][2]. However, there are other inheritance patterns, and genetic testing can help clarify your personal risk.
Hereditary spherocytosis is caused by changes (mutations) in the genes that provide instructions for building red blood cell membranes [3][4]. When these membranes are weakened, the red blood cells become sphere-shaped and are prematurely trapped and destroyed by the spleen [3][4].
Autosomal Dominant Inheritance (Most Common)
In roughly 75% of hereditary spherocytosis cases, the condition is autosomal dominant [1]. This means you only need one copy of the mutated gene to have the disease.
- If you have this form, you have a 50% (1 in 2) chance of passing the gene—and the condition—to each of your children [1][2].
- This form is most often linked to mutations in the ANK1, SPTB, or SLC4A1 genes [5][6].
Autosomal Recessive Inheritance (Less Common)
Less frequently, HS follows an autosomal recessive pattern, often involving the SPTA1 or EPB42 genes [7][8]. In recessive inheritance, a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
- If you have autosomal recessive HS, it means you have two copies of the mutated gene. You will definitely pass one copy to your child, making them a carrier [7].
- A “carrier” child who inherits only one mutated recessive gene will generally live a completely normal, healthy life without symptoms [9].
- Your child will only develop the disease if your partner also passes down a mutated gene. If your partner is not a carrier, your child’s risk of having the disease is effectively zero [9].
Spontaneous (De Novo) Mutations
Sometimes, a person is born with HS even though neither parent has the condition or carries the gene. This is called a de novo (new or spontaneous) mutation, and it most commonly occurs in the ANK1 gene [10][11]. If you are the first and only person in your family to have HS, you likely have a de novo mutation. If you have a de novo mutation, your chances of passing it to your children will follow the autosomal dominant pattern (a 50% chance) [11].
Family Planning and Genetic Counseling
Even within the same family, the severity of hereditary spherocytosis can vary widely from person to person [12][9]. Symptoms in a child could range from very mild (requiring no treatment) to more severe (requiring frequent blood transfusions or surgical removal of the spleen).
If you are the one carrying the child, you should also discuss the physical demands of pregnancy with your doctor. Pregnancy can place extra stress on your body, potentially worsening your anemia or increasing your risk of gallstones [12].
Because the genetics can be complex, working with a genetic counselor can be highly beneficial when planning a family [13]. A genetic counselor can help you:
- Identify your specific mutation: Genetic testing can confirm which gene is involved and determine whether your HS is dominant or recessive [1][14]. (Note: While genetic testing is highly accurate, there is a small chance it may not identify the specific causative mutation in every single patient).
- Screen your partner: If you have the recessive form, your partner can be tested to see if they are a carrier.
- Explore reproductive options: For families wishing to prevent the transmission of a known HS mutation, advanced options like preimplantation genetic testing (PGT) are available [15]. PGT is used during in vitro fertilization (IVF) to test embryos for the genetic mutation before they are implanted in the uterus.
Common questions in this guide
What are the chances I will pass hereditary spherocytosis to my child?
What happens if my hereditary spherocytosis is autosomal recessive?
Can a child get hereditary spherocytosis if neither parent has it?
Will my child have the same hereditary spherocytosis symptoms as I do?
How can a genetic counselor help with family planning?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my specific genetic mutation been identified, or should I undergo genetic testing to determine whether my hereditary spherocytosis is autosomal dominant or recessive?
- 2.If I have an autosomal recessive form, should my partner get a carrier screening?
- 3.What are my options for genetic counseling or family planning, such as preimplantation genetic testing (PGT)?
- 4.Is it possible my condition is a de novo (spontaneous) mutation, and how would that affect my children's risks?
- 5.How might pregnancy impact my own health (like my anemia or risk of gallstones) if I am the one carrying the child?
- 6.How might the severity of the disease in my child compare to my own symptoms?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
Novel nonsense mutation p. Gln264Ter in the ANK1 confirms causative role for hereditary spherocytosis: a case report.
Chai S, Jiao R, Sun X, et al.
BMC medical genetics 2020; (21(1)):223 doi:10.1186/s12881-020-01161-4.
PMID: 33187473 - 2
A novel essential splice site variant in SPTB in a large hereditary spherocytosis family.
Nieminen TT, Liyanarachchi S, Comiskey DF, et al.
Molecular genetics & genomic medicine 2021; (9(5)):e1641 doi:10.1002/mgg3.1641.
PMID: 33943044 - 3
Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis.
Zaninoni A, Vercellati C, Imperiali FG, et al.
Transfusion 2015; (55(12)):2930-8 doi:10.1111/trf.13257.
PMID: 26259504 - 4
Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study.
Pincez T, Guitton C, Gauthier F, et al.
Blood 2016; (127(12)):1616-8 doi:10.1182/blood-2015-11-679357.
PMID: 26773041 - 5
Clinical Characteristics and Gene Mutations of Hereditary Spherocytosis in 59 Chinese Children.
Li Y, Wang Y, Liu T, et al.
Molecular genetics & genomic medicine 2026; (14(3)):e70188 doi:10.1002/mgg3.70188.
PMID: 41721551 - 6
A large family of hereditary spherocytosis and a rare case of hereditary elliptocytosis with a novel SPTA1 mutation underdiagnosed in Taiwan: A case report and literature review.
Shih YH, Huang YC, Lin CY, et al.
Medicine 2023; (102(4)):e32708 doi:10.1097/MD.0000000000032708.
PMID: 36705355 - 7
Novel compound heterozygous mutations in the SPTA1 gene, causing hereditary spherocytosis in a neonate with Coombs‑negative hemolytic jaundice.
Wang X, Liu A, Lu Y, Hu Q
Molecular medicine reports 2019; (19(4)):2801-2807 doi:10.3892/mmr.2019.9947.
PMID: 30816434 - 8
A family affair-Severe fetal and neonatal hemolytic anemia due to novel alpha-spectrin mutations in two siblings.
Donepudi R, Westerfield L, Stonecipher A, et al.
American journal of medical genetics. Part A 2020; (182(3)):561-564 doi:10.1002/ajmg.a.61455.
PMID: 31854503 - 9
Clinical manifestations of 17 Chinese children with hereditary spherocytosis caused by novel mutations of the ANK1 gene and phenotypic analysis.
Kang M, Li H, Zhu J, et al.
Frontiers in genetics 2023; (14()):1088985 doi:10.3389/fgene.2023.1088985.
PMID: 36816036 - 10
Identification of a De Novoc.1000delA ANK1 mutation associated to hereditary spherocytosis in a neonate with Coombs-negative hemolytic jaundice-case reports and review of the literature.
Xie L, Xing Z, Li C, et al.
BMC medical genomics 2021; (14(1)):77 doi:10.1186/s12920-021-00912-3.
PMID: 33706756 - 11
Identification of a de novo ANK1 mutation in a Chinese family with hereditary spherocytosis.
Guan H, Liang X, Zhang R, et al.
Hematology (Amsterdam, Netherlands) 2018; (23(6)):357-361 doi:10.1080/10245332.2017.1398210.
PMID: 29099659 - 12
A novel splicing mutation of ANK1 is associated with phenotypic heterogeneity of hereditary spherocytosis in a Chinese family.
Xu L, Wei X, Liang G, et al.
Biochimica et biophysica acta. Molecular basis of disease 2023; (1869(1)):166595 doi:10.1016/j.bbadis.2022.166595.
PMID: 36336297 - 13
Identification of a novel heterozygous SPTB mutation by whole genome sequencing in a Chinese patient with hereditary spherocytosis and atrial septal defect: a case report.
Du Z, Luo G, Wang K, et al.
BMC pediatrics 2021; (21(1)):291 doi:10.1186/s12887-021-02771-4.
PMID: 34182956 - 14
Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations?
Häuser F, Rossmann H, Adenaeuer A, et al.
International journal of molecular sciences 2023; (24(23)) doi:10.3390/ijms242317021.
PMID: 38069343 - 15
Integrative preimplantation genetic testing analysis for a Chinese family with hereditary spherocytosis caused by a novel splicing variant of SPTB.
Tian Y, Wang Y, Yang J, et al.
Frontiers in genetics 2023; (14()):1221853 doi:10.3389/fgene.2023.1221853.
PMID: 37795245
This page provides educational information about the genetics of hereditary spherocytosis. Always consult a genetic counselor or hematologist for medical advice regarding your specific risks and family planning.
Get notified when new evidence is published on Hereditary spherocytosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.